119 related articles for article (PubMed ID: 26002573)
1. Postoperative dynamic changes in the concentration of CK19-2G2 in lung cancer patients and the clinical value of this marker.
Gao J; Lv F; Wang J; Wu Z; Li J; Yan C; Qi J
Tumour Biol; 2015 Nov; 36(11):8295-9. PubMed ID: 26002573
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokeratin 19 fragment, CK19-2G2, as a newly identified biomarker for lung cancer.
Gao J; Lv F; Li J; Wu Z; Qi J
PLoS One; 2014; 9(7):e101979. PubMed ID: 25006982
[TBL] [Abstract][Full Text] [Related]
3. [Detection of serum CK19-2G2 and Cyfra21-1 protein and comparison of their diagnostic value for lung cancer].
Gao J; Wang H; Qi J
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):930-2. PubMed ID: 19173996
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients.
Kong Y; Wang J; Liu W; Chen Q; Yang J; Wei W; Wu M; Yang L; Xie X; Lv N; Guo J; Li L; Gao J; Xie X; Dai S
PLoS One; 2013; 8(2):e57092. PubMed ID: 23468917
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of new tumor biomarker cytokeratin 2G2 detection in non-small cell lung cancer patients.
Liang ZK; Yin YJ; Wu ED; Shi GL
Clin Lab; 2013; 59(5-6):551-6. PubMed ID: 23865353
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of cytokeratin 19 fragment in nasopharyngeal carcinoma].
Lei DS; Yu J; Tong XL; Wang MW; Wang K; Chen H
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):461-5. PubMed ID: 22932457
[TBL] [Abstract][Full Text] [Related]
7. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period.
Ge MJ; Shi D; Wu QC; Wang M; Li LB
J Cancer Res Clin Oncol; 2006 Apr; 132(4):248-56. PubMed ID: 16320073
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of preoperative and postoperative cytokeratin 19 messenger RNA level in peripheral blood of esophageal cancer patients.
Qiao YF; Chen CG; Yue J; Ma Z; Yu ZT
Dis Esophagus; 2016 Nov; 29(8):929-936. PubMed ID: 26382739
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between the mRNA levels of carcinoembryonic antigen and cytokeratin 19 in peripheral blood with staging, treatment response and prognosis in patients with lung cancer].
Wang JH; Zhang SC; Liu ZD; Chen XY; Li CY; Han Y; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):773-6. PubMed ID: 16324274
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Serum CYFRA 21-1 and CK19-2G2 for Tumor Aggressiveness and Overall Survival in Hepatitis C-Related Hepatocellular Carcinoma Among Egyptians: A Prospective Study.
Taher MY; Hassouna EM; El-Hadidi AS; El-Aassar OS; Bakosh MF
J Gastrointest Cancer; 2024 Jun; 55(2):749-758. PubMed ID: 38231289
[TBL] [Abstract][Full Text] [Related]
11. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer.
Qiao YF; Chen CG; Yue J; Ma MQ; Ma Z; Yu ZT
World J Gastroenterol; 2017 Feb; 23(8):1424-1433. PubMed ID: 28293089
[TBL] [Abstract][Full Text] [Related]
13. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region.
Kaliszewski K; Diakowska D; Strutynska-Karpinska M; Rzeszutko M; Grzegrzolka J; Dziegiel P; Wojtczak B; Sutkowski K
Folia Histochem Cytobiol; 2016; 54(4):193-201. PubMed ID: 28051274
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of combined analysis of cytokeratin19 expression and preoperative serum CYFRA21-1 levels in human lung squamous cell carcinoma.
Hanada S; Nishiyama N; Mizuguchi S; Yamano S; Kakehashi A; Wei M; Inoue H; Komatsu H; Chung K; Suehiro S; Wanibuchi H
Osaka City Med J; 2013 Jun; 59(1):35-44. PubMed ID: 23909079
[TBL] [Abstract][Full Text] [Related]
16. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
Wang WB; Cui YG; Yao SY
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
[TBL] [Abstract][Full Text] [Related]
17. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of expressions of tumor markers in peripheral blood in non-small cell lung cancer].
Qu YM; Liao GQ; Liu PH; Wang HM; Liu L; Li LL; Xie GQ
Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1958-62. PubMed ID: 20979858
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
[TBL] [Abstract][Full Text] [Related]
20. OSNA: A Fast Molecular Test Based on CK19 mRNA Concentration for Assessment of EBUS-TBNA Samples in Lung Cancer Patients.
Oezkan F; Khan AM; Hager T; Freitag L; Christoph D; Darwiche K
Clin Lung Cancer; 2016 May; 17(3):198-204. PubMed ID: 26455862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
